Zennova Pharmaceuticals Group announced that it has received nearly CNY 100 million in a round of funding on July 21, 2023. The transaction included participation from new investor Hengbao Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 CNY | +0.32% | +2.27% | -17.84% |
Apr. 30 | Hengbao Co.,Ltd. Proposes Final Dividend for 2023 | CI |
Apr. 29 | Hengbao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.84% | 612M | |
+85.74% | 2,185B | |
+32.55% | 627B | |
+17.03% | 592B | |
+5.13% | 243B | |
+25.51% | 200B | |
-38.77% | 132B | |
+40.13% | 127B | |
+41.81% | 105B | |
+2.05% | 99B |
- Stock Market
- Equities
- 002104 Stock
- News Hengbao Co.,Ltd.
- Zennova Pharmaceuticals Group announced that it has received CNY 100 million in funding from Hengbao Co.,Ltd.